The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
about
Nectin-2 is a potential target for antibody therapy of breast and ovarian cancersTargeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical ApproachesBeyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint RegulatorsNatural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approachesThe role of natural cytotoxicity receptors in various pathologies: emphasis on type I diabetesTIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV InfectionIncreased CD112 expression in methylcholanthrene-induced tumors in CD155-deficient miceStructure of Nectin-2 reveals determinants of homophilic and heterophilic interactions that control cell-cell adhesionStructure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clusteringVstm3 is a member of the CD28 family and an important modulator of T-cell functionThe receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functionsCytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2ATIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy.Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT).DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins.Cancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets.T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2-mediated negative signalingNK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.Balancing natural killer cell activation through paired receptors.TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients.The class-specific BCR tonic signal modulates lymphomagenesis in a c-myc deregulation transgenic model.Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells.Cell surface signaling molecules in the control of immune responses: a tide model.Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation.The TIGIT/CD226 axis regulates human T cell functionThe Role of T Cell Costimulation via DNAM-1 in Kidney Transplantation.Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.TIGIT predominantly regulates the immune response via regulatory T cells.HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicityCellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells.Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells.TIGIT-positive circulating follicular helper T cells display robust B-cell help functions: potential role in sickle cell alloimmunization.Costimulatory and Coinhibitory Receptor Pathways in Infectious DiseaseImpaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulationInflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection.The CD226/CD155 interaction regulates the proinflammatory (Th1/Th17)/anti-inflammatory (Th2) balance in humans.PILRα binds an unknown receptor expressed primarily on CD56bright and decidual-NK cells and activates NK cell functionsProfiling the dynamic expression of checkpoint molecules on cytokine-induced killer cells from non-small-cell lung cancer patients.
P2860
Q24294932-F38BD44F-C9C3-494A-8B98-63A3239A729AQ26752518-4036CA50-075D-438D-9E46-1CA1096753D6Q26782799-AD8BD3FA-08AF-4A71-950C-0C61DD017AC8Q26825652-0397EB1A-CD7E-4CF3-AC87-416EEFC10429Q27003384-02569E8B-1C3D-48BA-8F18-00BCED4611EFQ27316403-463580F0-944F-4AC7-B07A-E1A6FD5BEBB6Q27330218-4891476C-ADD7-4703-9CBF-496B1F1D790AQ27671723-C0EB6C0A-C9E6-48B6-9C0F-B607DF8BCA6EQ27678057-574C070C-D704-4A19-A43B-AE215BB1E37BQ28512622-1D82E82C-06C3-439C-A666-62ACCD6F55DCQ28589215-399E840D-31FD-4F8C-9029-EA2945F55672Q28731856-609AE75C-1CDA-43FB-B0C8-3BF6638BFFDEQ30399437-E6A44C46-6DBF-4B8F-B0F7-4AB4DE7DA43BQ30402088-CAC9FC2B-1F54-482B-9A33-793C41FA3672Q30716850-E89E1854-FBEC-4646-8AAC-E98B37876325Q33731047-94F56521-E7F5-42FE-8A86-68516A56C01CQ33792958-612987AA-03ED-426F-9FE2-50F76119D9E5Q33798745-F71B9732-F910-455D-A008-4FE842062CF1Q33814908-F0198551-04A5-497E-89DD-0703F84BFCA5Q34043164-6C2504BD-DF7C-4BAE-ACC1-21D892A0DA5DQ34465877-AF40E105-DD64-47E3-AE3B-85E5CE98D45DQ34471375-304DB026-7A35-4AD4-B781-899EE4FEA30AQ34619195-354C7CEA-3D40-4A8C-8F35-A87EE0C08F2BQ35083496-F5DF1420-393A-445B-9A34-262B3B1ABBF3Q35223235-4914CDA1-7761-4AC4-B102-AB307AEBB350Q35546925-F8D0B909-57AB-4BE3-8973-FE91395B7940Q35884216-6C93EA12-6F88-4E2D-9D60-00B5816C24CEQ35913309-81DE1DBA-04A6-4E08-9F95-10B4EC6A311AQ35956678-E5341373-41D1-4B37-9F24-BCFEA164F37AQ36266506-9251F06E-2868-41A1-A5EE-568EB2AC8C87Q36544773-835F42A6-DFE5-4D71-B467-564A623993ECQ36570136-4286A0AE-4100-4A77-B385-0B7F045E86F8Q36603122-B8788F32-4F0A-4D73-BCE1-71801EB1E008Q36779751-585E51DE-E0B4-4274-B4B6-5E9F081A59D2Q36919711-96BE87CF-CA58-4C05-A831-C28AA432D49EQ36957280-AEE5D3D1-B28E-4350-BCE2-D0714C8CB0C4Q37197940-6EF6DAF7-5B55-40D9-9793-9AD814C355B5Q37285847-1CDDDB12-CBB9-446A-AB4A-C8F6CDC076A8Q37520120-6B53ABB1-DF95-48C9-8908-63AC053A86D0Q37536649-C1E425BF-C44C-4FD6-82A8-BFBBFB7E7E5E
P2860
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
@ast
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
@en
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
@nl
type
label
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
@ast
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
@en
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
@nl
prefLabel
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
@ast
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
@en
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
@nl
P2093
P2860
P50
P3181
P356
P1476
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
@en
P2093
Amir Toporik
Amit Novik
Hagit Achdout
Hrvoje Simic
Liat Dassa
Meirav Beiman
Noa Stanietsky
Ofer Mandelboim
Pinhas Tsukerman
P2860
P304
P3181
P356
10.1073/PNAS.0903474106
P407
P577
2009-10-20T00:00:00Z